Related Experiment Video
Updated: Jun 27, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Risk-adapted use of intravesical chemotherapy
1Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA. slerner@bcm.tmc.edu
BJU International
|November 28, 2008
Abstract
No abstract available in PubMed .
